"beta-Alanine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.
| Descriptor ID |
D015091
|
| MeSH Number(s) |
D12.125.042.070
|
| Concept/Terms |
beta-Alanine- beta-Alanine
- beta Alanine
- 3-Aminopropionic Acid
- 3 Aminopropionic Acid
|
Below are MeSH descriptors whose meaning is more general than "beta-Alanine".
Below are MeSH descriptors whose meaning is more specific than "beta-Alanine".
This graph shows the total number of publications written about "beta-Alanine" by people in this website by year, and whether "beta-Alanine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2011 | 3 | 0 | 3 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 1 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "beta-Alanine" by people in Profiles.
-
Netarsudil for the Treatment of Open-Angle Glaucoma and Ocular Hypertension: A Literature Review. Ann Pharmacother. 2021 08; 55(8):1025-1036.
-
Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol. 2014 Dec; 11(12):693-703.
-
Fatal dabigatran-associated bleeding. Am J Health Syst Pharm. 2014 Mar 01; 71(5):360.
-
Reply to comments on "evaluation of dabigatran exposures reported to poison centers". Ann Pharmacother. 2014 May; 48(5):664-5.
-
Evaluation of dabigatran exposures reported to poison control centers. Ann Pharmacother. 2014 Mar; 48(3):354-60.
-
Fatal bleeding associated with dabigatran. Am J Health Syst Pharm. 2013 Oct 01; 70(19):1651-2.
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):1144-50.
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2011 Mar 15; 57(11):1330-7.
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Mar; 8(3):e1-8.
-
The effects of beta-alanine supplementation and high-intensity interval training on neuromuscular fatigue and muscle function. Eur J Appl Physiol. 2009 Feb; 105(3):357-63.